✦ LIBER ✦

Consequences of increased vascular permeability induced by treatment of mice with 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and thalidomide

✍ Scribed by Francisco Chung; Jenny Liu; Lai-Ming Ching; Bruce C. Baguley

Publisher: Springer
Year: 2007
Tongue: English
Weight: 316 KB
Volume: 61
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-007-0495-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of tumor vascular shutdown in

Mechanisms of tumor vascular shutdown induced by 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Increased tumor vascular permeability

✍ Liangli Zhao; Lai-Ming Ching; Philip Kestell; Lloyd R. Kelland; Bruce C. Baguley 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB

## Abstract The novel vascular targeting agent 5,6‐dimethylxanthenone‐4‐acetic acid (DMXAA) has completed phase 1 clinical trial and has shown tumor antivascular activity in both mice and humans. We have investigated its ability to change tumor vascular permeability, relating it to tumor vascular p

Modulation of the pharmacokinetics of th

Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide

✍ Philip Kestell; Liangli Zhao; Bruce C. Baguley; Brian D. Palmer; George Muller; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 141 KB

Modulation of thalidomide pharmacokineti

Modulation of thalidomide pharmacokinetics by cyclophosphamide or 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice: the role of tumour necrosis factor

✍ Francisco Chung; Liang-ChuanS. Wang; Philip Kestell; BruceC. Baguley; Lai-Ming C 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 267 KB